A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy
Broad Institute · Harvard University · +11 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
238
total citations
- FWCI
- 59.66
- Percentile
- 100%
- References
- 122
Citations per year
Authors
12- DMDavid M. Cordas dos SantosCorresponding
Broad Institute, Harvard University, LMU Klinikum, Dana-Farber Cancer Institute, Massachusetts Institute of Technology, Ludwig-Maximilians-Universität München
- TTTobias Tix
LMU Klinikum, Ludwig-Maximilians-Universität München
- RSRoni Shouval
Memorial Sloan Kettering Cancer Center, Cornell University
- AGAnat Gafter‐Gvili
Tel Aviv University, Rabin Medical Center
- JAJean-Baptiste Alberge
Broad Institute, Harvard University, Dana-Farber Cancer Institute, Massachusetts Institute of Technology
Topics & keywords
Topics
Keywords
- Meta-analysis
- Medicine
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- YUYale University
- MSMemorial Sloan-Kettering Cancer CenterAward: CA008748
- MCMoffitt Cancer Center
- YCYale Cancer Center
- AVArnold Ventures
- DFDeutsche ForschungsgemeinschaftAwards: 452881907, 391587558, P30 CA008748, 451580403, SFB-TRR 388/1 2021 - 452881907
- DKDeutschen Konsortium für Translationale Krebsforschung
- NINational Institutes of HealthAward: P30 CA008748
- UOUniversity of Texas MD Anderson Cancer CenterAward: P30 CA008748
- NCNational Cancer InstituteAwards: K08CA282987, CA008748, P30 CA008748